Literature DB >> 28694264

Medication-Assisted Treatment Should Be Part of Every Family Physician's Practice: Yes.

David Loxterkamp1.   

Abstract

Keywords:  buprenorphine; naloxone drug combination; opiate substitution therapy; opioid; opioid-related disorders; physician; prescribing patterns; primary health care

Mesh：

Substances：

Year:  2017        PMID： 28694264      PMCID： PMC5505447          DOI： 10.1370/afm.2103

Source DB:  PubMed          Journal:  Ann Fam Med        ISSN： 1544-1709            Impact factor:   5.166


× No keyword cloud information.
  6 in total

1.  Now is the Time to Address Substance Use Disorders in Primary Care.

Authors:  Richard Saitz; Timothy P Daaleman
Journal:  Ann Fam Med       Date:  2017-07       Impact factor: 5.166

2.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

3.  Nudging primary care providers to expand the opioid use disorder workforce.

Authors:  Marisa Elena Domino; Sean Sylvia; Sherri Green
Journal:  Health Serv Res       Date:  2021-11-07       Impact factor: 3.402

4.  Launching a Medication-Assisted Treatment in an Outpatient Office-Based Practice.

Authors:  Julienne K Kirk; Tamela Yount; Charlotte T Boyd; Lisa Cassidy-Vu; Aubry N Koehler; John G Spangler
Journal:  J Prim Care Community Health       Date:  2020 Jan-Dec

5.  Acute pain management among patients with opioid maintenance therapy: specificities and difficulties identified in primary care: a qualitative study.

Authors:  Morgane Guillou Landreat; Melia Baillot; Delphine Le Goff; Jean Yves Le Reste
Journal:  BMJ Open       Date:  2021-01-19       Impact factor: 2.692

6.  Prospective Study on Factors Associated with Referral of Patients with Opioid Maintenance Therapy from Specialized Addictive Disorders Centers to Primary Care.

Authors:  Morgane Guillou-Landreat; Philippe Levassor; Marylène Guerlais; Veronique Sebille; Caroline Victorri-Vigneau
Journal:  Int J Environ Res Public Health       Date:  2021-05-27       Impact factor: 3.390
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.